McDermott, D., Huseni, M., Atkins, M., Motzer, R., Rini, B., Escudier, B., Fong, L., Joseph, R., Pal, S., Reeves, J., Sznol, M., Hainsworth, J., Rathmell, W., Stadler, W., Hutson, T., Gore, M., Ravaud, A., Bracarda, S., Suárez, C., Danielli, R., Gruenwald, V., Choueiri, T., Nickles, D., Jhunjhunwala, S., Piault-Louis, E., Thobhani, A., Qiu, J., Chen, D., Hegde, P., Schiff, C., Fine, G., & Powles, T. (2018). publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nature medicine, 24, 1941. http://access.bl.uk/ark:/81055/vdc_100099708611.0x00014a